Single dose of BNT162b2 mRNA vaccine against SARS-CoV-2 induces high frequency of neutralising antibody and polyfunctional T-cell responses in patients with myeloproliferative neoplasms.
Patrick HarringtonHugues de LavalladeKatie J DooresAmy O'ReillyJeffrey SeowCarl GrahamThomas LechmereDeepti RadiaRichard DillonYogita ShanmugharajAndreas EspehanaClaire WoodleyJamie SaundersNatalia Curto-GarciaJennifer O'SullivanKavita RajShahram KordastiMichael H MalimClaire N HarrisonDonal P McLornanPublished in: Leukemia (2021)